Sees FY25 adjusted operating earnings $105M-$130M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SUPN:
- Supernus Pharmaceuticals Updates Executive Compensation Packages
- SUPN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Cantor downgrades Supernus on ‘disappointing’ depression study
- Supernus downgraded to Neutral from Overweight at Cantor Fitzgerald
- Closing Bell Movers: Shift4 down 10%, Penumbra up 8% after results
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue